Document is current

Article History

Received: 2 May 2018

Accepted: 27 November 2018

First Online: 12 December 2018

Authors’ information

: N M-C: Ph.D. (concentration: systems biology, bioinformatics, and genomics of dilated cardiomyopathy), Clinical Science Ph.D. program, Department of Medicine (Grad), Colorado Clinical and Translational Sciences Institute Ph.D. certificate program, TL1 trainee, University of Colorado, Denver. Master in Advanced Studies in Clinical Research (concentration: genomics of hypertension): University of California San Diego. Master in Clinical Science (concentration: systems biology, bioinformatics and genomics of rare cardiomyopathies): University of Colorado, Denver.DW: Department of Biostatistics, School of Public Health, University of Colorado, Denver.IC: Bachelor of Science, Stanford University.RS: Principal dealer. Schmidt Motors, Ogallala, Nebraska.CH: Professor, Department of Genetics, Louisiana State University Health Sciences Center.MM: Assistant Professor of research, Dept. of Pharmacology, U. Colorado School of Medicine.DI: Associate Professor, Dept. of Cardio Vascular Pulmonary Research, U. Colorado School of Medicine.JT: Associate Professor, division of medical oncology, U. Colorado School of Medicine.

: Not applicable. Data utilized in this study are secondary data, de-identified, free open source, and available online to the public. No approval from the ethics committee was required. Consent to participate: Public. Data utilized in this study are secondary data, de-identified, free open source, and available online to the public.

: Public. Data utilized in this study are secondary data, de-identified, free open source, and available online to the public. This study did not involve human subjects.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.